We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+2.52%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$7.16B
AUM Growth
+$666M
(+10%)
Cap. Flow
+$831M
Cap. Flow
% of AUM
11.61%
Top 10 Holdings %
Top 10 Hldgs %
17.05%
Holding
983
New
189
Increased
207
Reduced
145
Closed
240
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$146M |
| 2 |
Gilead Sciences
GILD
|
+$116M |
| 3 |
Amazon
AMZN
|
+$86.4M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$84.7M |
| 5 |
Analog Devices
ADI
|
+$80M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$73.2M |
| 2 |
Palo Alto Networks
PANW
|
+$59.8M |
| 3 |
Alkermes
ALKS
|
+$55.3M |
| 4 |
Accenture
ACN
|
+$53.8M |
| 5 |
Johnson & Johnson
JNJ
|
+$53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 36.05% |
| 2 | Technology | 29.2% |
| 3 | Financials | 8.76% |
| 4 | Industrials | 7.7% |
| 5 | Communication Services | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $346M | 4.84% |
969,000
| – | – |
|
|
HZNP
2
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $144M | 2.01% |
2,326,663
+2,088,635
| +877% | +$146M |
|
|
3
Gilead Sciences
GILD
$161B
| $140M | 1.95% |
2,262,691
+1,844,728
| +441% | +$116M |
|
|
4
Regeneron Pharmaceuticals
REGN
$68.8B
| $129M | 1.8% |
187,357
+134,565
| +255% | +$84.7M |
|
|
5
Eli Lilly
LLY
$1.07T
| $85.7M | 1.2% |
265,099
-230,904
| -47% | -$73.2M |
|
6
Merck
MRK
$324B
| $84.3M | 1.18% |
978,487
+412,503
| +73% | +$36.8M |
|
|
7
Amazon
AMZN
$2.5T
| $77.2M | 1.08% |
+683,398
| New | +$86.4M |
|
8
Medtronic
MDT
$107B
| $76.3M | 1.07% |
944,872
+367,291
| +64% | +$33M |
|
|
9
Analog Devices
ADI
$181B
| $70.5M | 0.98% |
+505,773
| New | +$80M |
|
10
Teradyne
TER
$54.8B
| $67.2M | 0.94% |
893,762
+716,124
| +403% | +$65.3M |
|
11
STMicroelectronics
STM
$46B
| $63.5M | 0.89% |
2,051,114
-1,121,002
| -35% | -$39.4M |
|
12
L3Harris
LHX
$55.9B
| $63.4M | 0.89% |
305,160
+156,937
| +106% | +$36.2M |
|
13
Huntington Ingalls Industries
HII
$11.3B
| $61.1M | 0.85% |
276,006
+76,585
| +38% | +$17.2M |
|
14
HCA Healthcare
HCA
$84.8B
| $60M | 0.84% |
+326,514
| New | +$65M |
|
15
Meta Platforms (Facebook)
META
$1.51T
| $57.6M | 0.81% |
+424,832
| New | +$68.9M |
|
16
Vishay Intertechnology
VSH
$5.86B
| $54.5M | 0.76% |
3,061,528
+365,637
| +14% | +$7.13M |
|
17
Cigna
CI
$76.6B
| $54.4M | 0.76% |
196,138
+122,240
| +165% | +$34.4M |
|
18
Arrow Electronics
ARW
$10.9B
| $54.3M | 0.76% |
588,896
-40,476
| -6% | -$4.42M |
|
19
Skyworks Solutions
SWKS
$9.06B
| $54M | 0.76% |
633,683
-321,977
| -34% | -$32.9M |
|
20
Dell
DELL
$283B
| $53.2M | 0.74% |
1,556,741
+1,084,642
| +230% | +$45.7M |
|
21
Viavi Solutions
VIAV
$9.75B
| $52.8M | 0.74% |
4,046,643
+1,967,867
| +95% | +$28M |
|
22
Danaher
DHR
$135B
| $51.1M | 0.71% |
+223,061
| New | +$54.6M |
|
23
Leidos
LDOS
$14.1B
| $49.7M | 0.69% |
+567,768
| New | +$55.5M |
|
24
ASML
ASML
$675B
| $49.5M | 0.69% |
119,204
-9,138
| -7% | -$4.58M |
|
25
Boston Scientific
BSX
$65.8B
| $49M | 0.68% |
1,265,340
-996,652
| -44% | -$40M |
|
Similar funds
KAS
PAM
TCIIS
Woodline Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Woodline Partners held 983 positions worth $7.16B, up 10% from $6.49B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Woodline Partners deployed $831M of net new capital in Q3 2022, opening 189 new positions and adding to 207 existing holdings. Its largest new stake was Amazon: 683,398 shares worth $77.2M.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $73.2M trimmed.
- Woodline Partners's largest Q3 2022 buy was Amazon: 683,398 shares worth $77.2M.
- Woodline Partners added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2022, an estimated $146M increase.
- Woodline Partners's biggest Q3 2022 reduction was Eli Lilly, cutting an estimated $73.2M.
- Woodline Partners fully exited Palo Alto Networks in Q3 2022, selling an estimated $59.8M.
- Woodline Partners's ten largest holdings make up 17% of its $7.16B portfolio in Q3 2022.
- Woodline Partners opened 189 new positions and closed 240 in Q3 2022.
- Woodline Partners's portfolio value rose 10% quarter-over-quarter to $7.16B.
Based on Woodline Partners's 13F filing for Q3 2022, filed 14 Nov 2022.